Skip to main content

Is Therapy Working?

Repeatable, radiation-free cognitive monitoring

Get Ceregram(™) Today!

For ongoing monitoring of patients under care for cognitive impairment

Problem

Today, patients and their doctors lack objective, repeatable tools to evaluate therapeutic effects. The consequence is that personal treatment plans may be ineffective for years without knowing. This is a terrible loss of time and money during the most critical window of opportunity for treatment.

Vision

We imagine a future where dementia patients and their doctors quickly track near-term response to therapy so they know when therapy is working (and when it isn’t). In this way, treatment plan are quickly adjusted based on progress, so patients benefit from the best possible outcomes: slowing, stopping, and in best cases, reversal of decline.

Mission

Our goal is to provide a technology which empowers physicians with superior clinical decision making abilities at their own clinic and with a single, easy assessment for precise tracking of neurological diseases over time and across all relevant disease endpoints, including amyloid and tau accumulations, neurodegeneration, and cognitive symptoms. We make progress towards our mission every day, via research partnerships, clinical studies, and peer-reviewed publications.

Learn more about our approach

Recent News

Vistim Labs publishes updated findings in Alzheimer’s Research and Therapy Journal

Read more

Vistim Labs Launches at American Academy of Neurology 2025

Read more
HITLAB and Vistim Labs partner on brain mapping solutions

HITLAB Partners with Vistim Labs for Brain Disease Monitoring Validation Study

Read more
Vistim Labs presents at AAIC 2023

Vistim Labs unveils new biomarkers at the Alzheimer’s Association International Conference

Read more
Vistim Labs Wins 1st at Inventures 2023

Vistim Labs wins 1st at Inventions Health Competition

Read more
Vistim Labs EEG evidence separating neurodegenerative endpoints

Vistim Labs publishes new findings in Alzheimer’s Research and Therapy Journal

Read more
Vistim Labs wins 1st at Startup San Diego

Vistim Labs wins 1st at Startup San Diego Competition

Read more
Vistim Labs graduates from PharmStars accelerator

Vistim Labs 1 of 11 graduates from exclusive Boston Biotech Accelerator: PharmStars

Read more

Disclaimer: Ceregram(™) is intended for cognitive monitoring only. It is not for diagnosing, treating, curing, or preventing any disease. It is not a diagnostic nor meant to replace other diagnostic modalities.